Drug recall D-0241-2026
Product
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland, NDC 0006-3066-03
Reason for recall
Presence of particulate matter: potential presence of metal particulates in the product.
Lots and codes
Lot #: Z014503, Exp 11/15/2027
Recall details
- Recalling firm
- Merck Sharp & Dohme LLC, Wilson, NC
- Quantity
- 3 - single dose kits
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 12, 2025
Related products
- Emend – drug information
- NDC 0006-0462 Emend · Aprepitant 125 mg/1 · Merck Sharp & Dohme LLC
- NDC 0006-0461 Emend · Aprepitant 80 mg/1 · Merck Sharp & Dohme LLC
- NDC 0006-0464 Emend · Aprepitant 40 mg/1 · Merck Sharp & Dohme LLC
- NDC 0006-3862 Emend · · Merck Sharp & Dohme LLC
- NDC 0006-3066 Emend · Aprepitant 125 mg/1 · Merck Sharp & Dohme LLC